{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T13:33:30Z","timestamp":1791812010527,"version":"4.3.4"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:00:00Z","timestamp":1776988800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:00:00Z","timestamp":1776988800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sleep Breath"],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Obstructive sleep apnea (OSA) is strongly associated with obesity, and weight loss is a cornerstone of its management. Glucagon-like peptide-1 receptor agonists (GLP-1 RAs), are a class of medications that induce significant weight loss and have shown promise in improving OSA severity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>This meta-analysis aimed to evaluate the pooled efficacy of GLP-1 RAs on sleep-disordered breathing, body weight, and cardiovascular risk factors in patients with OSA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A systematic review and meta-analysis of four randomized controlled trials were performed, comparing GLP-1 RA therapy with placebo in adults with OSA. The primary outcomes analyzed were the mean differences in the change from baseline for the apnea-hypopnea index (AHI), body weight, and systolic and diastolic blood pressure.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In the pooled analysis, treatment with GLP-1 RAs was associated with a robust and statistically significant reduction in AHI (mean difference [MD]: -13.89 events\/hour;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.01). Therapy also resulted in substantial weight loss compared to placebo (MD: -12.46\u00a0kg;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.01). For cardiovascular parameters, the use of GLP-1 RA was associated with a significant reduction in systolic blood pressure (mean difference [MD]: -4.86 mmHg;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.01) and diastolic blood pressure (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.03).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>GLP-1 receptor agonists significantly reduce OSA severity, promote substantial weight loss, and lower systolic and diastolic blood pressure in patients with obstructive sleep apnea and obesity. These findings support the role of GLP-1 RAs as a multifaceted and effective therapeutic intervention for managing OSA.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11325-026-03681-4","type":"journal-article","created":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T13:57:03Z","timestamp":1777039023000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Efficacy of GLP-1 Receptor agonists in treating Obstructive sleep apnea: A systematic review and meta-analysis of cardiometabolic and respiratory outcomes"],"prefix":"10.1007","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-3580-0783","authenticated-orcid":false,"given":"Mrunalini","family":"Dandamudi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larissa","family":"Lucena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole Norma","family":"Gamarra-Valverde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Tripoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinh Quang Tri","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Samaniego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Pinilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Macarena","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salomon","family":"Chamay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana","family":"Giorgi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Barbagelata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edgardo","family":"Kaplinsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,24]]},"reference":[{"issue":"13","key":"3681_CR1","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1056\/NEJMoa2404881","volume":"391","author":"A Malhotra","year":"2024","unstructured":"Malhotra A, Grunstein RR, Fietze I, Weaver TE, Redline S, Azarbarzin A (2024) Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity. N Engl J Med 391(13):1193\u20131205","journal-title":"N Engl J Med"},{"issue":"8","key":"3681_CR2","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1038\/ijo.2016.52","volume":"40","author":"A Blackman","year":"2016","unstructured":"Blackman A, Foster GD, Zammit G, Rosenberg R, Aronne L, Wadden T (2016) Effect of liraglutide 3.0 mg in individuals with obesity and moderate or severe obstructive sleep apnea: the SCALE Sleep Apnea randomized clinical trial. Int J Obes (Lond) 40(8):1310\u20131319","journal-title":"Int J Obes (Lond)"},{"issue":"2","key":"3681_CR3","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1093\/sleep\/29.2.240","volume":"29","author":"CA Kushida Jr","year":"2006","unstructured":"Kushida CA Jr, Littner MR, Morgenthaler T, Alessi CA, Bailey D, Coleman J (2006) Practice parameters for the treatment of snoring and obstructive sleep apnea with oral appliances: an update for 2005. Sleep 29(2):240\u2013243","journal-title":"Sleep"},{"issue":"2","key":"3681_CR4","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s11325-021-02412-1","volume":"26","author":"C Antonaglia","year":"2022","unstructured":"Antonaglia C, Passuti G (2022) Obstructive sleep apnea syndrome in non-obese patients. Sleep Breath 26(2):513\u2013518","journal-title":"Sleep Breath"},{"issue":"8","key":"3681_CR5","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1038\/s41569-023-00846-6","volume":"20","author":"S Redline","year":"2023","unstructured":"Redline S, Azarbarzin A, Peker Y (2023) Obstructive sleep apnoea heterogeneity and cardiovascular disease. Nat Rev Cardiol 20(8):560\u2013573","journal-title":"Nat Rev Cardiol"},{"issue":"4","key":"3681_CR6","doi-asserted-by":"publisher","first-page":"296","DOI":"10.21053\/ceo.2025-00071","volume":"18","author":"YJ Kang","year":"2025","unstructured":"Kang YJ, Park C-S (2025) Mechanisms and management of obstructive sleep apnea: A translational overview. Clin Exp Otorhinolaryngol 18(4):296\u2013305","journal-title":"Clin Exp Otorhinolaryngol"},{"key":"3681_CR7","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1007\/s11325-022-02768-y","volume":"27","author":"W Jiang","year":"2023","unstructured":"Jiang W, Li W, Cheng J, Li W, Cheng F (2023) Efficacy and safety of liraglutide in patients with type 2 diabetes mellitus and severe obstructive sleep apnea. Sleep Breath 27:1687\u20131694","journal-title":"Sleep Breath"},{"issue":"9","key":"3681_CR8","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.3390\/diagnostics15091088","volume":"15","author":"G De Iannella","year":"2025","unstructured":"De Iannella G, Marchese Pace A, Bellizzi MG, Magliulo G, Greco A, Virgilio A, Croce E, Gioacchini FM, Re M, Costantino A, Casale M, Moffa A, Lechien JR, Cocuzza S, Vicini C, Caranti A, Aragona R, Lentini M, Maniaci A (2025) The Global Burden of Obstructive Sleep Apnea. Diagnostics (Basel) 15(9):1088. https:\/\/doi.org\/10.3390\/diagnostics15091088. (PMID: 40361906; PMCID: PMC12071658)","journal-title":"Diagnostics (Basel)"},{"issue":"5","key":"3681_CR9","first-page":"920","volume":"7","author":"JF Garvey","year":"2015","unstructured":"9.Garvey JF, Pengo MF, Drakatos P, Kent BD (2015) Epidemiological aspects of obstructive sleep apnea. J Thorac Dis 7(5):920\u2013929","journal-title":"J Thorac Dis"},{"issue":"7","key":"3681_CR10","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1111\/resp.13838","volume":"25","author":"MM Lyons","year":"2020","unstructured":"Lyons MM, Bhatt NY, Pack AI, Magalang UJ (2020) Global burden of sleep-disordered breathing and its implications. Respirology 25(7):690\u2013702","journal-title":"Respirology"},{"issue":"2","key":"3681_CR11","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1513\/pats.200708-138MG","volume":"5","author":"AR Schwartz","year":"2008","unstructured":"11.Schwartz AR, Patil SP, Laffan AM, Polotsky V, Schneider H, Smith PL (2008) Obesity and obstructive sleep apnea: pathogenic mechanisms and therapeutic approaches. Proc Am Thorac Soc 5(2):185\u2013192. https:\/\/doi.org\/10.1513\/pats.200708-138MG","journal-title":"Proc Am Thorac Soc"},{"issue":"9","key":"3681_CR12","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1164\/rccm.2109080","volume":"165","author":"T Young","year":"2002","unstructured":"12.Young T, Peppard PE, Gottlieb DJ (2002) Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med 165(9):1217\u20131239. https:\/\/doi.org\/10.1164\/rccm.2109080","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"3681_CR13","doi-asserted-by":"publisher","first-page":"846","DOI":"10.7326\/0003-4819-141-11-200412070-00008","volume":"141","author":"K Spiegel","year":"2004","unstructured":"Spiegel K, Tasali E, Penev P, Van Cauter E (2004) Sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite. Ann Intern Med 141(11):846\u201350. https:\/\/doi.org\/10.7326\/0003-4819-141-11-200412070-00008","journal-title":"Ann Intern Med"},{"issue":"2","key":"3681_CR14","doi-asserted-by":"publisher","first-page":"193","DOI":"10.5664\/jcsm.5472","volume":"12","author":"A Shechter","year":"2016","unstructured":"14.Shechter A, St-Onge MP (2016) Delayed sleep timing is associated with increased snack intake and lower diet quality in healthy adults: a cross-sectional study. J Clin Sleep Med 12(2):193\u2013199. https:\/\/doi.org\/10.5664\/jcsm.5472","journal-title":"J Clin Sleep Med"},{"key":"3681_CR15","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.smrv.2014.07.003","volume":"20","author":"L Lavie","year":"2015","unstructured":"15.Lavie L (2015) Oxidative stress in obstructive sleep apnea and intermittent hypoxia\u2014revisited\u2014the bad ugly and good: implications to the heart and brain. Sleep Med Rev 20:27\u201345. https:\/\/doi.org\/10.1016\/j.smrv.2014.07.003","journal-title":"Sleep Med Rev"},{"issue":"8","key":"3681_CR16","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.jacc.2016.11.069","volume":"69","author":"S Javaheri","year":"2017","unstructured":"Javaheri S, Barbe F, Campos-Rodriguez F et al (2017) Sleep apnea: types, mechanisms, and clinical cardiovascular consequences. J Am Coll Cardiol 69(8):841\u2013858. https:\/\/doi.org\/10.1016\/j.jacc.2016.11.069","journal-title":"J Am Coll Cardiol"},{"issue":"9918","key":"3681_CR17","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/S0140-6736(13)60734-5","volume":"383","author":"AS Jordan","year":"2014","unstructured":"17.Jordan AS, McSharry DG, Malhotra A (2014) Adult obstructive sleep apnoea. Lancet 383(9918):736\u2013747","journal-title":"Lancet"},{"issue":"10","key":"3681_CR18","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1161\/CIRCULATIONAHA.107.189420","volume":"118","author":"VK Somers","year":"2008","unstructured":"Somers VK, White DP, Amin R, Abraham WT, Costa F, Culebras A (2008) Sleep apnea and cardiovascular disease: An American Heart Association\/American College of Cardiology Foundation Scientific Statement. Circulation 118(10):1080\u20131111","journal-title":"Circulation"},{"issue":"1","key":"3681_CR19","first-page":"93","volume":"26","author":"X Jiang","year":"2022","unstructured":"Jiang X, Zhao Y, Li X, Zhu H, Liu Y, Zhang Z (2022) Intermittent hypoxia and the pathogenesis of cardiovascular diseases in obstructive sleep apnea. Sleep Breath 26(1):93\u2013101","journal-title":"Sleep Breath"},{"issue":"3","key":"3681_CR20","first-page":"zsaa175","volume":"44","author":"A de Malhotra","year":"2021","unstructured":"de Malhotra A, Patil SP, Ayappa I, Ayas N, Carden KA, Chazal P (2021) Metrics of sleep apnea severity: beyond the apnea\u2013hypopnea index. Sleep 44(3):zsaa175","journal-title":"Sleep"},{"key":"3681_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2020.101102","volume":"46","author":"MA Nauck","year":"2021","unstructured":"Nauck MA, Quast DR, Wefers J, Meier JJ (2021) GLP-1 receptor agonists in the treatment of type 2 diabetes \u2013 state-of-the-art. Mol Metab 46:101102. https:\/\/doi.org\/10.1016\/j.molmet.2020.101102","journal-title":"Mol Metab"},{"issue":"2","key":"3681_CR22","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1513\/pats.200708-119MG","volume":"5","author":"TE Weaver","year":"2008","unstructured":"22.Weaver TE, Grunstein RR (2008) Adherence to continuous positive airway pressure therapy: the challenge to effective treatment. Proc Am Thorac Soc 5(2):173\u2013178","journal-title":"Proc Am Thorac Soc"},{"issue":"7","key":"3681_CR23","first-page":"1210","volume":"28","author":"RF Kushner","year":"2020","unstructured":"Kushner RF, Calanna S, Davies M, Dicker D, Goldman B, Lingvay I (2020) Clinical characteristics and adverse events of glucagon-like peptide-1 receptor agonists in the treatment of obesity. Obes (Silver Spring) 28(7):1210\u20131219","journal-title":"Obes (Silver Spring)"},{"key":"3681_CR24","unstructured":"U.S. Food and Drug Administration. FDA approves first medication for obstructive sleep apnea [Internet]. Silver Spring (MD): FDA; (2024) Jun 17 [cited 2025 Jul 16]"},{"issue":"10","key":"3681_CR25","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1056\/NEJMoa1606599","volume":"375","author":"RD McEvoy","year":"2016","unstructured":"McEvoy RD, Antic NA, Heeley E et al (2016) CPAP for prevention of cardiovascular events in obstructive sleep apnea. N Engl J Med 375(10):919\u201331","journal-title":"N Engl J Med"},{"issue":"4","key":"3681_CR26","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1056\/NEJMoa1603827","volume":"375","author":"SP Marso","year":"2016","unstructured":"Marso SP, Daniels GH, Brown-Frandsen K et al (2016) Liraglutide and cardiovascular outcomes in type 2 diabetes. N Engl J Med 375(4):311\u201322","journal-title":"N Engl J Med"},{"issue":"10193","key":"3681_CR27","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S0140-6736(19)31149-3","volume":"394","author":"HC Gerstein","year":"2019","unstructured":"Gerstein HC, Colhoun HM, Dagenais GR (2019) Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomized placebo-controlled trial. Lancet 394(10193):121\u2013130","journal-title":"Lancet"},{"issue":"2","key":"3681_CR28","first-page":"179","volume":"34","author":"JB Pietzsch","year":"2011","unstructured":"Pietzsch JB (2011) Long-term cost-effectiveness of CPAP therapy in patients with moderate to severe OSA. Sleep 34(2):179\u2013188","journal-title":"Sleep"},{"issue":"14","key":"3681_CR29","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1093\/ajhp\/zxae105","volume":"81","author":"EM Tichy","year":"2024","unstructured":"Tichy EM, Hoffman JM, Tadrous M, Rim MH, Cuellar S, Clark JS et al (2024) National trends in prescription drug expenditures and projections for 2024. Am J Health-Syst Pharm 81(14):583\u2013598","journal-title":"Am J Health-Syst Pharm"},{"issue":"3","key":"3681_CR30","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/zsaf407","volume":"49","author":"KP Strohl","year":"2025","unstructured":"Strohl KP (2025) The source of the Nile. Sleep zsaf407. https:\/\/doi.org\/10.1093\/sleep\/zsaf407","journal-title":"Sleep"},{"issue":"4","key":"3681_CR31","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/zsae280","volume":"48","author":"M Li","year":"2025","unstructured":"Li M, Lin H, Yang Q, Zhang X, Zhou Q, Shi J, Ge F (2025) Glucagon-like peptide-1 receptor agonists for the treatment of obstructive sleep apnea: a meta-analysis. Sleep 48(4):zsae280. https:\/\/doi.org\/10.1093\/sleep\/zsae280","journal-title":"Sleep"},{"issue":"1","key":"3681_CR32","first-page":"23","volume":"12","author":"L Yang","year":"2025","unstructured":"Yang L, Zhang M, Wu S, Zhou L, Li Y, Liu D (2025) The effect of GLP-1 receptor agonists on obstructive sleep apnea in patients with obesity or diabetes: a systematic review and meta-analysis. Sleep Apnea J 12(1):23\u201334","journal-title":"Sleep Apnea J"},{"key":"3681_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.smrv.2024.101761","volume":"69","author":"CS Kow","year":"2025","unstructured":"Kow CS, Hasan SS, Naing L, Merchant HA (2025) Effects of GLP-1 receptor agonists on obstructive sleep apnea severity: a systematic review and meta-analysis of clinical trials. Sleep Med Rev 69:101761. https:\/\/doi.org\/10.1016\/j.smrv.2024.101761","journal-title":"Sleep Med Rev"}],"container-title":["Sleep and Breathing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11325-026-03681-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11325-026-03681-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11325-026-03681-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:40:42Z","timestamp":1781649642000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11325-026-03681-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,24]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["3681"],"URL":"https:\/\/doi.org\/10.1007\/s11325-026-03681-4","relation":{},"ISSN":["1520-9512","1522-1709"],"issn-type":[{"value":"1520-9512","type":"print"},{"value":"1522-1709","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,24]]},"assertion":[{"value":"9 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. This is a meta-analysis. The Sirio Libanes Research Ethics Committee has confirmed that no ethical approval is required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Consent to publish"}},{"value":"All authors certify that they have no affiliations with or involvement in any organization or entity with any financial or non-financial interest in the subject matter or materials discussed in this manuscript.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Competing Interests"}}],"article-number":"138"}}